Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Kodiak Sciences (KOD) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Aflibercept, Tabirafusp Tedromer, EyleaDiabetic Macular Edema (Dme)Phase IIIRecruitingA Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTOMay 30, 2026―
Sham Comparator, Ksi-101Macular Edema Secondary To InflammationPhase IIIRecruitingA Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLEMay 21, 2025
Sham Comparator, Ksi-101Macular Edema Secondary To InflammationPhase IIIRecruitingA Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAKMay 17, 2025
Aflibercept, Tarcocimab Tedromer, Tabirafusp TedromerWet Age-Related Macular DegenerationPhase IIIActive Not RecruitingA Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAKAug 12, 2024―
Sham Injection, TarcocimabDiabetic RetinopathyPhase IIIActive Not RecruitingA Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)Feb 14, 2024―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Kodiak Sciences (KOD) have in its pipeline
Kodiak Sciences KOD is currently developing the following drugs: Aflibercept, Tabirafusp Tedromer, Eylea, Sham Comparator, Ksi-101, Aflibercept, Tarcocimab Tedromer, Tabirafusp Tedromer, Sham Injection, Tarcocimab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.